Sagimet Biosciences (SGMT) Q4 2024 Annual Earnings
SGMT·Reported March 12, 2025·Before market open
Diluted EPS came in at $-0.50, beat the $-0.65 consensus by $0.15.
Diluted EPS
$-0.50beat by $0.15
Consensus: $-0.65
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Sagimet Biosciences's Q4 2024 earnings report.
Sagimet Biosciences (SGMT) reported Q4 2024 earnings on March 12, 2025 before market open.
Sagimet Biosciences reported diluted EPS of $-0.50 for Q4 2024.
EPS beat the consensus estimate of $-0.65 by $0.15.
You can read the 10-K periodic report (0001558370-25-002747) directly on SEC EDGAR. The filing index links above go to sec.gov.